RE-BVS – Piemonte Repository

Sfoglia per AUTORE
KULASEKARARAJ AG
Collezione AOU Città della Salute di Torino

Items : 3

Phase 3 randomized COMMODORE 1 trial: Crovalimab versus eculizumab in complement inhibitor-experienced patients with paroxysmal nocturnal hemoglobinuria. in American journal of hematology / Am J Hematol. 2024 Sep;99(9):1757-1767. doi: 10.1002/ajh.27413. Epub 2024 Jun 25.

2024
AOU Città della Salute di Torino

Kiialainen A; Gentile B; Buatois S; Panse J; Ueda Y; Lekue CB; Lee Y; Giai V; Hus M; Bonito D; Barcellini W; Yenerel MN; Nur E; Kim JS; Clé DV; Scheinberg P; Patel H; Sreckovic S; Uguen M; Edwards J; Nagy Z; Kulasekararaj AG;

Oral Iptacopan Monotherapy in Paroxysmal Nocturnal Hemoglobinuria. in The New England journal of medicine / N Engl J Med. 2024 Mar 14;390(11):994-1008. doi: 10.1056/NEJMoa2308695.

2024
AOU Città della Salute di Torino

Peffault de Latour R; Röth A; Kulasekararaj AG; Han B; Scheinberg P; Maciejewski JP; Ueda Y; de Castro CM; Di Bona E; Fu R; Zhang L; Griffin M; Langemeijer SMC; Panse J; Schrezenmeier H; Barcellini W; Mauad VAQ; Schafhausen P; Tavitian S; Beggiato E; Chew LP; Gaya A; Huang WH; Jang JH; Kitawaki T; Kutlar A; Notaro R; Pullarkat V; Schubert J; et alii...

Impact of somatic mutations in myelodysplastic patients with isolated partial or total loss of chromosome 7. in Leukemia / Leukemia. 2020 Sep;34(9):2441-2450. doi: 10.1038/s41375-020-0728-x. Epub 2020 Feb 17.

2020
AOU Città della Salute di Torino

Santini V; Martínez ABV; Hildebrandt B; Germing U; Ferrero D; Lea N; Cervera J; Kizilors A; Mian SA; Best S; Shirneshan K; Haase D; Schanz J; Such E; Adema V; Kulasekararaj AG; Crisà E; Sanz GF; Solé F; Mufti GJ;